Curevac N V 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2024 to a ratio of 74.27, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2024. Average receivable collection period, for the Curevac N V in Dec 31 2024 quarter, has decreased to 5 days, compared to 9 days, in the 0 quarter.

If we take a look into Healthcare sector 32 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 474, from overall ranking in the third quarter 2024 at 3401.

What is Receivable Turnover Ratio?
What is Curevac N V Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CVAC Receivables Turnover Ratio	(Dec 31 2024) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Receivable Change	-1.74 %	-1.74 %	-1.74 %	-1.74 %	1312.82 %
Y / Y Revenue Change	895.54 %	2924.68 %	88.34 %	75.59 %	10 %
Receivable Turnover Ratio (TTM)	74.27	39.9	6.73	6.25	5.86
CVAC's Total Ranking	# 474	# 3401	#	#	#
Accounts Receivable average collection period days	5	9	54	58	62
Seq. Receivable Change	0 %	0 %	0 %	-1.74 %	0 %
Seq. Revenue Change	10.46 %	3391.52 %	15.72 %	-77.69 %	235.61 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 17
Healthcare Sector	# 33
Overall Market	# 474

Receivable Turnover Ratio Statistics
High	Average	Low
34.33	13.31	2.23
(Dec 31 2024)		(Dec 31 2020)

CVAC Company Profile • Back to CVAC Efficiency Comparisons • Compare CVAC Receivables Turnover Ratio to its Competitors

Financial Statements
Curevac N V 's Accounts Receivable	$ 16 Millions	Visit CVAC's Balance sheet
Curevac N V 's Sales TTM	$ 1,171 Millions	Visit CVAC's Income Statement
Sources of CVAC's Revenues		Visit CVAC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CVAC's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CVAC's Growth Rates	CVAC's Roa	CVAC's Inventory Turnover Ratio	CVAC's Dividend Comparisons
CVAC's Profitability Ratios	CVAC's Roi	CVAC's Asset Turnover Ratio	CVAC's Dividend Growth
CVAC's Valuation Ratios	CVAC's Roe	CVAC's Financial Strength Ratios	CVAC's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2024	Receivable at quarter ending Dec 31 2024
Wave Life Sciences Ltd	159.74	$ 108.302 Millions	$ 0.678 Millions
Polomar Health Services, Inc.	130.60	$ 0.059 Millions	$ 0.000 Millions
Healthlynked Corp	123.12	$ 3.008 Millions	$ 0.024 Millions
Earth Science Tech Inc	122.75	$ 30.456 Millions	$ 0.248 Millions
Lipocine Inc	120.71	$ 11.336 Millions	$ 0.094 Millions
Nakamoto Inc	114.63	$ 2.720 Millions	$ 0.024 Millions
Logicmark Inc	100.94	$ 9.902 Millions	$ 0.098 Millions
Orthofix Medical Inc	99.67	$ 798.885 Millions	$ 8.016 Millions
Stoke Therapeutics Inc	85.66	$ 36.555 Millions	$ 0.427 Millions
Nektar Therapeutics	81.80	$ 98.427 Millions	$ 1.203 Millions
Xortx Therapeutics inc	77.12	$ 1.360 Millions	$ 0.018 Millions
Airsculpt Technologies Inc	76.52	$ 180.350 Millions	$ 2.357 Millions
Lifevantage Corp	65.65	$ 211.272 Millions	$ 3.218 Millions
Mersana Therapeutics inc	63.03	$ 40.497 Millions	$ 0.643 Millions
Brookdale Senior Living Inc	61.19	$ 3,125.487 Millions	$ 51.080 Millions
Zeo Scientifix Inc	59.36	$ 4.556 Millions	$ 0.077 Millions
Lucid Diagnostics Inc	59.33	$ 4.346 Millions	$ 0.073 Millions
23andme Holding Co	55.62	$ 207.779 Millions	$ 3.736 Millions
Aclaris Therapeutics Inc	55.10	$ 18.720 Millions	$ 0.340 Millions
Longduoduo Co Ltd	49.77	$ 6.007 Millions	$ 0.121 Millions
Nature s Sunshine Products inc	43.36	$ 453.688 Millions	$ 10.464 Millions
Pavmed Inc	40.61	$ 3.249 Millions	$ 0.080 Millions
Metagenomi Therapeutics Inc	37.51	$ 52.295 Millions	$ 1.394 Millions
Blue Water Vaccines Inc	33.93	$ 2.524 Millions	$ 0.074 Millions
One World Products Inc	33.83	$ 0.005 Millions	$ 0.000 Millions
Curevac N v	33.79	$ 599.402 Millions	$ 17.739 Millions
Lifemd Inc	33.53	$ 211.815 Millions	$ 6.318 Millions
Xoma Royalty Corporation	33.39	$ 28.487 Millions	$ 0.853 Millions
Vivos Therapeutics Inc	33.30	$ 15.019 Millions	$ 0.451 Millions
Electrocore Inc	33.28	$ 24.397 Millions	$ 0.733 Millions

Date modified: 2026-08-30T09:00:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.